https://www.biospace.com/agios-to-present-broad-set-of-clinical-and-translational-data-for-oncology-and-rare-genetic-disease-programs-at-the-virtual-2020-ash-annual-meetingcompany-to-host-virtual-investor-event-and-webcast-on-tuesday-december-8-2020-at-8-00-a-m-et
Agios Pharmaceuticals, Inc. (NASDAQ:AGIO), a leader in the field of cellular metabolism to treat cancer and rare genetic diseases, today announced that a broad...
agiospresentbroadsetclinical
https://www.livescience.com/health/heart-circulation/diagnostic-dilemma-a-rare-genetic-disease-stained-a-womans-heart-black
An older woman had a relatively common heart problem, but it had a very rare cause.
rare genetic diseasediagnosticdilemmastainedwoman
https://globalnews.ca/news/2223539/rare-genetic-disease-diagnosed-in-3-kids-from-same-saskatoon-family/
A Saskatoon family with three children diagnosed with the rare genetic disease Morquio Syndrome is waiting to hear on funding for Vimizim therapy.
rare genetic diseasediagnosedkidssaskatoon
https://www.ksl.com/article/51424183/how-a-rare-genetic-disease-changed-all-her-plans
Jan 2, 2026 - Tiffany Fransen shares what life is like with Friedreich's ataxia, a rare genetic disease.
rare genetic diseaseall her planschangedksl
https://market.us/report/rare-disease-genetic-testing-market/
Rare Disease Genetic Testing Market Size is expected to be worth around USD 3,051.6 Mn by 2032 from USD 918.94 Mn in 2023.
rare diseasegenetic testingmarket sizecagr
https://www.popsci.com/article/science/microchip-heart-has-rare-genetic-disease/
The heart was created, in part, using skin cells from people with Barth syndrome.
rare genetic diseasemicrochipheart
https://www.sciencedaily.com/releases/2024/10/241017113712.htm
New research demonstrates the potential of precise genome editing technologies, called adenine base editors, to correct disease-causing mutations in stem cells...
gene editingthe wayapproachpavesfirst
https://www.techtarget.com/healthtechanalytics/news/366590531/AI-Supports-Clinical-Trial-for-Rare-Genetic-Disease-Treatment
Artificial intelligence supported a clinical trial that found that low-dose ketamine could be a therapeutic target for a rare genetic disease.
rare genetic diseaseclinical trialaitreatmenttechtarget